Nectar Lifesciences Q2 Results
- BSE: 532649
- NSE: NECLIFE
- ISIN: INE023H01027
- Sector: Biotechnology & Drugs
BSE
12.17
-0.17 (-1.38%)
-0.17 (-1.38%)Volume46.83 K
Updated: Tue 21 Apr, 2026 | 15:29:28
NSE
12.11-0.18 (-1.46%)
-0.18 (-1.46%)Volume2.32 L
Updated: Tue 21 Apr, 2026 | 15:29:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Nectar Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6.24 | 359.08 | -98.26% | 6.77 | -7.80% |
| Depreciation/ Amortization | 0.20 | 16.52 | -98.76% | 0.45 | -54.64% |
| Operating Income | -0.53 | -78.41 | -99.32% | -1.04 | -48.77% |
| Net Income | -,176.01 | -63.23 | 178.35% | 5.60 | 0.00% |
| Other Operating Expenses Total | 1.93 | 54.76 | -96.47% | 1.72 | 12.53% |
| Net Income Before Taxes | -0.51 | -96.75 | -99.48% | -0.35 | 44.46% |
| Total Revenue | 5.71 | 280.67 | -97.97% | 5.73 | -0.38% |
| Selling/ General/ Admin Expenses Total | 0.75 | 24.26 | -96.90% | 0.68 | 10.06% |
| Diluted Normalized EPS | -0.01 | -2.82 | -99.48% | -0.01 | 44.30% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.